Loading…

Biological markers in cerebrospinal fluid (CSF) and evaluation of in vitro effect of CSF on PC12 cell line viability in Alzheimer's disease

The definite diagnosis of Alzheimer's disease (AD) is based on post mortem pathological examination. To date, there is no laboratory test that can discriminate AD patients from healthy individuals. In the perspective of recent knowledge, there are three cerebrospinal fluid (CSF) markers which h...

Full description

Saved in:
Bibliographic Details
Published in:Cell biochemistry and function 2009-08, Vol.27 (6), p.395-401
Main Authors: Yaka, Erdem, Egrilmez, Mehtap Yuksel, Keskinoglu, Pembe, Cavdar, Zahide, Genc, Sermin, Genc, Kursad, İyilikci, Leyla, Yener, Görsev G.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c3888-b901f7b8f44a46f2949de00cccb3a554ebdb5ba85aed793c81b59e3ecff0569e3
cites cdi_FETCH-LOGICAL-c3888-b901f7b8f44a46f2949de00cccb3a554ebdb5ba85aed793c81b59e3ecff0569e3
container_end_page 401
container_issue 6
container_start_page 395
container_title Cell biochemistry and function
container_volume 27
creator Yaka, Erdem
Egrilmez, Mehtap Yuksel
Keskinoglu, Pembe
Cavdar, Zahide
Genc, Sermin
Genc, Kursad
İyilikci, Leyla
Yener, Görsev G.
description The definite diagnosis of Alzheimer's disease (AD) is based on post mortem pathological examination. To date, there is no laboratory test that can discriminate AD patients from healthy individuals. In the perspective of recent knowledge, there are three cerebrospinal fluid (CSF) markers which have the highest sensitivity and specificity: Aβ1–40, Aβ1–42, and p‐tau. In the present study, 15 ‘Probable Alzheimer's Disease’ (PAD) patients and 15 control subjects were included. PAD patients were selected from the patients of Dokuz Eylül University Neurology Department Dementia outpatient clinic and control subjects were selected from the patients who were undergone epidural anesthesia because of any surgical operation. The concentrations of Ab1–40, Ab1–42, and p‐tau in CSF were quantified by using ELISA. Also, the effects of ‘PAD patients’ CSF on the survival of PC12 cell line were assessed. There was a significant decrease of Ab1–40 and increase of p‐tau in patients with AD when compared with controls. Ab1–42 concentration was not significantly different between groups. There was a positive corelation between duration of the disease and CSF of p‐tau concentration in patients with AD. There was no significant difference in cell line viability values between groups. Copyright © 2009 John Wiley & Sons, Ltd.
doi_str_mv 10.1002/cbf.1588
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20708997</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20708997</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3888-b901f7b8f44a46f2949de00cccb3a554ebdb5ba85aed793c81b59e3ecff0569e3</originalsourceid><addsrcrecordid>eNp1kc9u1DAQhy1ERbcFiSdAPkE5pNixk9jHNuoWpAoqlT8SF8t2xmDwJoudtF1egZfG0UblxGlGns8_jb5B6Dklp5SQ8o017pRWQjxCK0qkLIjg_DFakbJmRc0FP0RHKf0ghMiakSfokOYqq0as0J9zP4Thm7c64I2OPyEm7HtsIYKJQ9r6Pg9cmHyHT9qb9Wus-w7DrQ6THv3Q48HN-K0f44DBObDj_JRJnIfXLS1zVAg4-B4ypY0PftzNX87C7-_gNxBfJdz5BDrBU3TgdEjwbKnH6NP64mP7trj6cPmuPbsqLBNCFEYS6hojHOea166UXHZAiLXWMF1VHExnKqNFpaFrJLOCmkoCA-scqercHaOX-9xtHH5NkEa18WleU_cwTEmVpCFCyiaDJ3vQZhUpglPb6LOlnaJEzeJVFq9m8Rl9sWROZgPdP3AxnYFiD9z5ALv_Bqn2fL0ELrxPI9w_8PlEqm5YU6kv7y8V-VxeU8Zv1Ff2FwHxnEQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20708997</pqid></control><display><type>article</type><title>Biological markers in cerebrospinal fluid (CSF) and evaluation of in vitro effect of CSF on PC12 cell line viability in Alzheimer's disease</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Yaka, Erdem ; Egrilmez, Mehtap Yuksel ; Keskinoglu, Pembe ; Cavdar, Zahide ; Genc, Sermin ; Genc, Kursad ; İyilikci, Leyla ; Yener, Görsev G.</creator><creatorcontrib>Yaka, Erdem ; Egrilmez, Mehtap Yuksel ; Keskinoglu, Pembe ; Cavdar, Zahide ; Genc, Sermin ; Genc, Kursad ; İyilikci, Leyla ; Yener, Görsev G.</creatorcontrib><description>The definite diagnosis of Alzheimer's disease (AD) is based on post mortem pathological examination. To date, there is no laboratory test that can discriminate AD patients from healthy individuals. In the perspective of recent knowledge, there are three cerebrospinal fluid (CSF) markers which have the highest sensitivity and specificity: Aβ1–40, Aβ1–42, and p‐tau. In the present study, 15 ‘Probable Alzheimer's Disease’ (PAD) patients and 15 control subjects were included. PAD patients were selected from the patients of Dokuz Eylül University Neurology Department Dementia outpatient clinic and control subjects were selected from the patients who were undergone epidural anesthesia because of any surgical operation. The concentrations of Ab1–40, Ab1–42, and p‐tau in CSF were quantified by using ELISA. Also, the effects of ‘PAD patients’ CSF on the survival of PC12 cell line were assessed. There was a significant decrease of Ab1–40 and increase of p‐tau in patients with AD when compared with controls. Ab1–42 concentration was not significantly different between groups. There was a positive corelation between duration of the disease and CSF of p‐tau concentration in patients with AD. There was no significant difference in cell line viability values between groups. Copyright © 2009 John Wiley &amp; Sons, Ltd.</description><identifier>ISSN: 0263-6484</identifier><identifier>EISSN: 1099-0844</identifier><identifier>DOI: 10.1002/cbf.1588</identifier><identifier>PMID: 19639578</identifier><language>eng</language><publisher>Chichester, UK: John Wiley &amp; Sons, Ltd</publisher><subject>Aged ; Alzheimer Disease - cerebrospinal fluid ; Alzheimer Disease - diagnosis ; Alzheimer's disease ; Amyloid beta-Peptides - cerebrospinal fluid ; Amyloid beta-Peptides - toxicity ; Animals ; Biomarkers - cerebrospinal fluid ; Cell Survival ; Chi-Square Distribution ; CSF markers ; cytotoxicity ; Cytotoxins - cerebrospinal fluid ; Cytotoxins - toxicity ; Dementia ; Female ; Humans ; Male ; Middle Aged ; PC12 cell line ; PC12 Cells ; Peptide Fragments - cerebrospinal fluid ; Peptide Fragments - toxicity ; Rats ; ROC Curve ; Statistics, Nonparametric ; tau ; tau Proteins - cerebrospinal fluid ; tau Proteins - toxicity</subject><ispartof>Cell biochemistry and function, 2009-08, Vol.27 (6), p.395-401</ispartof><rights>Copyright © 2009 John Wiley &amp; Sons, Ltd.</rights><rights>(c) 2009 John Wiley &amp; Sons, Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3888-b901f7b8f44a46f2949de00cccb3a554ebdb5ba85aed793c81b59e3ecff0569e3</citedby><cites>FETCH-LOGICAL-c3888-b901f7b8f44a46f2949de00cccb3a554ebdb5ba85aed793c81b59e3ecff0569e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19639578$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yaka, Erdem</creatorcontrib><creatorcontrib>Egrilmez, Mehtap Yuksel</creatorcontrib><creatorcontrib>Keskinoglu, Pembe</creatorcontrib><creatorcontrib>Cavdar, Zahide</creatorcontrib><creatorcontrib>Genc, Sermin</creatorcontrib><creatorcontrib>Genc, Kursad</creatorcontrib><creatorcontrib>İyilikci, Leyla</creatorcontrib><creatorcontrib>Yener, Görsev G.</creatorcontrib><title>Biological markers in cerebrospinal fluid (CSF) and evaluation of in vitro effect of CSF on PC12 cell line viability in Alzheimer's disease</title><title>Cell biochemistry and function</title><addtitle>Cell Biochem. Funct</addtitle><description>The definite diagnosis of Alzheimer's disease (AD) is based on post mortem pathological examination. To date, there is no laboratory test that can discriminate AD patients from healthy individuals. In the perspective of recent knowledge, there are three cerebrospinal fluid (CSF) markers which have the highest sensitivity and specificity: Aβ1–40, Aβ1–42, and p‐tau. In the present study, 15 ‘Probable Alzheimer's Disease’ (PAD) patients and 15 control subjects were included. PAD patients were selected from the patients of Dokuz Eylül University Neurology Department Dementia outpatient clinic and control subjects were selected from the patients who were undergone epidural anesthesia because of any surgical operation. The concentrations of Ab1–40, Ab1–42, and p‐tau in CSF were quantified by using ELISA. Also, the effects of ‘PAD patients’ CSF on the survival of PC12 cell line were assessed. There was a significant decrease of Ab1–40 and increase of p‐tau in patients with AD when compared with controls. Ab1–42 concentration was not significantly different between groups. There was a positive corelation between duration of the disease and CSF of p‐tau concentration in patients with AD. There was no significant difference in cell line viability values between groups. Copyright © 2009 John Wiley &amp; Sons, Ltd.</description><subject>Aged</subject><subject>Alzheimer Disease - cerebrospinal fluid</subject><subject>Alzheimer Disease - diagnosis</subject><subject>Alzheimer's disease</subject><subject>Amyloid beta-Peptides - cerebrospinal fluid</subject><subject>Amyloid beta-Peptides - toxicity</subject><subject>Animals</subject><subject>Biomarkers - cerebrospinal fluid</subject><subject>Cell Survival</subject><subject>Chi-Square Distribution</subject><subject>CSF markers</subject><subject>cytotoxicity</subject><subject>Cytotoxins - cerebrospinal fluid</subject><subject>Cytotoxins - toxicity</subject><subject>Dementia</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>PC12 cell line</subject><subject>PC12 Cells</subject><subject>Peptide Fragments - cerebrospinal fluid</subject><subject>Peptide Fragments - toxicity</subject><subject>Rats</subject><subject>ROC Curve</subject><subject>Statistics, Nonparametric</subject><subject>tau</subject><subject>tau Proteins - cerebrospinal fluid</subject><subject>tau Proteins - toxicity</subject><issn>0263-6484</issn><issn>1099-0844</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNp1kc9u1DAQhy1ERbcFiSdAPkE5pNixk9jHNuoWpAoqlT8SF8t2xmDwJoudtF1egZfG0UblxGlGns8_jb5B6Dklp5SQ8o017pRWQjxCK0qkLIjg_DFakbJmRc0FP0RHKf0ghMiakSfokOYqq0as0J9zP4Thm7c64I2OPyEm7HtsIYKJQ9r6Pg9cmHyHT9qb9Wus-w7DrQ6THv3Q48HN-K0f44DBObDj_JRJnIfXLS1zVAg4-B4ypY0PftzNX87C7-_gNxBfJdz5BDrBU3TgdEjwbKnH6NP64mP7trj6cPmuPbsqLBNCFEYS6hojHOea166UXHZAiLXWMF1VHExnKqNFpaFrJLOCmkoCA-scqercHaOX-9xtHH5NkEa18WleU_cwTEmVpCFCyiaDJ3vQZhUpglPb6LOlnaJEzeJVFq9m8Rl9sWROZgPdP3AxnYFiD9z5ALv_Bqn2fL0ELrxPI9w_8PlEqm5YU6kv7y8V-VxeU8Zv1Ff2FwHxnEQ</recordid><startdate>200908</startdate><enddate>200908</enddate><creator>Yaka, Erdem</creator><creator>Egrilmez, Mehtap Yuksel</creator><creator>Keskinoglu, Pembe</creator><creator>Cavdar, Zahide</creator><creator>Genc, Sermin</creator><creator>Genc, Kursad</creator><creator>İyilikci, Leyla</creator><creator>Yener, Görsev G.</creator><general>John Wiley &amp; Sons, Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>200908</creationdate><title>Biological markers in cerebrospinal fluid (CSF) and evaluation of in vitro effect of CSF on PC12 cell line viability in Alzheimer's disease</title><author>Yaka, Erdem ; Egrilmez, Mehtap Yuksel ; Keskinoglu, Pembe ; Cavdar, Zahide ; Genc, Sermin ; Genc, Kursad ; İyilikci, Leyla ; Yener, Görsev G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3888-b901f7b8f44a46f2949de00cccb3a554ebdb5ba85aed793c81b59e3ecff0569e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Aged</topic><topic>Alzheimer Disease - cerebrospinal fluid</topic><topic>Alzheimer Disease - diagnosis</topic><topic>Alzheimer's disease</topic><topic>Amyloid beta-Peptides - cerebrospinal fluid</topic><topic>Amyloid beta-Peptides - toxicity</topic><topic>Animals</topic><topic>Biomarkers - cerebrospinal fluid</topic><topic>Cell Survival</topic><topic>Chi-Square Distribution</topic><topic>CSF markers</topic><topic>cytotoxicity</topic><topic>Cytotoxins - cerebrospinal fluid</topic><topic>Cytotoxins - toxicity</topic><topic>Dementia</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>PC12 cell line</topic><topic>PC12 Cells</topic><topic>Peptide Fragments - cerebrospinal fluid</topic><topic>Peptide Fragments - toxicity</topic><topic>Rats</topic><topic>ROC Curve</topic><topic>Statistics, Nonparametric</topic><topic>tau</topic><topic>tau Proteins - cerebrospinal fluid</topic><topic>tau Proteins - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yaka, Erdem</creatorcontrib><creatorcontrib>Egrilmez, Mehtap Yuksel</creatorcontrib><creatorcontrib>Keskinoglu, Pembe</creatorcontrib><creatorcontrib>Cavdar, Zahide</creatorcontrib><creatorcontrib>Genc, Sermin</creatorcontrib><creatorcontrib>Genc, Kursad</creatorcontrib><creatorcontrib>İyilikci, Leyla</creatorcontrib><creatorcontrib>Yener, Görsev G.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Cell biochemistry and function</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yaka, Erdem</au><au>Egrilmez, Mehtap Yuksel</au><au>Keskinoglu, Pembe</au><au>Cavdar, Zahide</au><au>Genc, Sermin</au><au>Genc, Kursad</au><au>İyilikci, Leyla</au><au>Yener, Görsev G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biological markers in cerebrospinal fluid (CSF) and evaluation of in vitro effect of CSF on PC12 cell line viability in Alzheimer's disease</atitle><jtitle>Cell biochemistry and function</jtitle><addtitle>Cell Biochem. Funct</addtitle><date>2009-08</date><risdate>2009</risdate><volume>27</volume><issue>6</issue><spage>395</spage><epage>401</epage><pages>395-401</pages><issn>0263-6484</issn><eissn>1099-0844</eissn><abstract>The definite diagnosis of Alzheimer's disease (AD) is based on post mortem pathological examination. To date, there is no laboratory test that can discriminate AD patients from healthy individuals. In the perspective of recent knowledge, there are three cerebrospinal fluid (CSF) markers which have the highest sensitivity and specificity: Aβ1–40, Aβ1–42, and p‐tau. In the present study, 15 ‘Probable Alzheimer's Disease’ (PAD) patients and 15 control subjects were included. PAD patients were selected from the patients of Dokuz Eylül University Neurology Department Dementia outpatient clinic and control subjects were selected from the patients who were undergone epidural anesthesia because of any surgical operation. The concentrations of Ab1–40, Ab1–42, and p‐tau in CSF were quantified by using ELISA. Also, the effects of ‘PAD patients’ CSF on the survival of PC12 cell line were assessed. There was a significant decrease of Ab1–40 and increase of p‐tau in patients with AD when compared with controls. Ab1–42 concentration was not significantly different between groups. There was a positive corelation between duration of the disease and CSF of p‐tau concentration in patients with AD. There was no significant difference in cell line viability values between groups. Copyright © 2009 John Wiley &amp; Sons, Ltd.</abstract><cop>Chichester, UK</cop><pub>John Wiley &amp; Sons, Ltd</pub><pmid>19639578</pmid><doi>10.1002/cbf.1588</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0263-6484
ispartof Cell biochemistry and function, 2009-08, Vol.27 (6), p.395-401
issn 0263-6484
1099-0844
language eng
recordid cdi_proquest_miscellaneous_20708997
source Wiley-Blackwell Read & Publish Collection
subjects Aged
Alzheimer Disease - cerebrospinal fluid
Alzheimer Disease - diagnosis
Alzheimer's disease
Amyloid beta-Peptides - cerebrospinal fluid
Amyloid beta-Peptides - toxicity
Animals
Biomarkers - cerebrospinal fluid
Cell Survival
Chi-Square Distribution
CSF markers
cytotoxicity
Cytotoxins - cerebrospinal fluid
Cytotoxins - toxicity
Dementia
Female
Humans
Male
Middle Aged
PC12 cell line
PC12 Cells
Peptide Fragments - cerebrospinal fluid
Peptide Fragments - toxicity
Rats
ROC Curve
Statistics, Nonparametric
tau
tau Proteins - cerebrospinal fluid
tau Proteins - toxicity
title Biological markers in cerebrospinal fluid (CSF) and evaluation of in vitro effect of CSF on PC12 cell line viability in Alzheimer's disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T14%3A11%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biological%20markers%20in%20cerebrospinal%20fluid%20(CSF)%20and%20evaluation%20of%20in%20vitro%20effect%20of%20CSF%20on%20PC12%20cell%20line%20viability%20in%20Alzheimer's%20disease&rft.jtitle=Cell%20biochemistry%20and%20function&rft.au=Yaka,%20Erdem&rft.date=2009-08&rft.volume=27&rft.issue=6&rft.spage=395&rft.epage=401&rft.pages=395-401&rft.issn=0263-6484&rft.eissn=1099-0844&rft_id=info:doi/10.1002/cbf.1588&rft_dat=%3Cproquest_cross%3E20708997%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3888-b901f7b8f44a46f2949de00cccb3a554ebdb5ba85aed793c81b59e3ecff0569e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20708997&rft_id=info:pmid/19639578&rfr_iscdi=true